Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bio Farma Urges OIC Countries to Strengthen Vaccine Cooperation

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Bio Farma to make OIC Countries self-reliance in vaccine industry.

Bio Farma has urged Organization of Islamic Cooperation (OIC) member countries to strengthen cooperation in vaccine research to make them self-reliance in vaccine industry.

"We need to strengthen our collaboration in research, production and supply of biological products related to vaccine," Bio Farma President Director Iskandar (one name) said in his presentation in front of vaccine experts attending the 2nd meeting of OIC vaccine & medicine manufacturers, in Bandung, on Sunday.

Prior to Iskandar's presentation on OIC vaccine industry cooperation, delegates from nine OIC member countries (which already have vaccine-making companies or institutions) had approved appointment of Juliman (one name), Bio Farma Director of Production, as chair of the meeting that runs from 16 to 19 June, 2013.

Iskandar emphasized the importance of vaccine research and production among OIC member countries to make them self-reliant in vaccine industry.

He noted the experience of Indonesia, being the world's largest Moslem nation with a population of 240 million, whose need of vaccine has been supplied by the 123-year-old Bio Farma.

For the shorter term period, he said Bio Farma wishes to strengthen the cooperation among Islamic countries in vaccine production while for the medium term it wants to jointly develop new vaccines which are needed by Islamic countries.

Delegates attending the meeting enthusiastically welcomed Indonesia's ideas for an increased cooperation in vaccine research and production to make them self-reliant in vaccine supplies for meeting their needs of vaccine.

Iran and Saudi Arabia, especially, had appreciated Bio Farma's offer for cooperation and initiative on vaccine self-reliance among Islamic countries.

Indonesia's decision to host the meeting is a follow up to the decision of the meeting of Islamic Countries' Advisory Group in Ankara Turkey and the 6th meeting of the OIC Steering Committee on Health in Jakarta.

In addition, the Indonesian government through the letter of the Secretary General of the Ministry of Health to OIC Secretary General has also expressed willingness to host a meeting to finalize the implementation plan for Strategic Health Action Programme 2013-2022.

Bio Farma itself is Indonesia's only vaccine manufacturer whose some of its products have been recognized by the World Health Organization (WHO) so that the company can supply its products to over 100 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly.

WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are exported to countries around the world through the direct distribution or through various agencies such as UNICEF and PAHO.

The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010, 2011 and 2012 as an evidence of its consistent exceptional performance.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bio Farma Offers Partnerships in Vaccine Development
Company to partner with vaccine manufacturers in developing and Islamic countries.
Monday, October 29, 2012
Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!